Similar articles

• The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents.

  Scaf AH, van den Akker J, Berends F. Scaf AH, et al. Arch Int Pharmacodyn Ther. 1974 Mar;208(1):166-76. Arch Int Pharmacodyn Ther. 1974. PMID: 4276930 No abstract available.
• The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium.

  Scaf AH, van den Akker J, Westenberg HG. Scaf AH, et al. Arch Int Pharmacodyn Ther. 1974 Mar;208(1):177-92. Arch Int Pharmacodyn Ther. 1974. PMID: 4846189 No abstract available.
• [Inhibition of cholinesterase in the myoneural synapses by decamethonium and ditilin].

  Danilov AF. Danilov AF. Farmakol Toksikol. 1967 Nov-Dec;30(6):664-9. Farmakol Toksikol. 1967. PMID: 5598433 Russian. No abstract available.
• [Experimental study on the mechanism of action of Mylaxen and a review of the literature].

  Takeda M. Takeda M. Masui. 1967 Dec;16(12):1039-47. Masui. 1967. PMID: 4873212 Review. Japanese. No abstract available.
• Neuromuscular blocking drugs in anaesthesia.

  Donati F, Bevan JC, Bevan DR. Donati F, et al. Can Anaesth Soc J. 1984 May;31(3 Pt 1):324-36. doi: 10.1007/BF03007899. Can Anaesth Soc J. 1984. PMID: 6372957 Review. No abstract available.